Page last updated: 2024-10-30

meclofenamic acid and Myocardial Infarction

meclofenamic acid has been researched along with Myocardial Infarction in 2 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Szekeres, L1
Papp, JG1
Szilvássy, Z1
Udvary, E1
Vegh, A1
Liu, GS1
Stanley, AW1
Downey, J1

Other Studies

2 other studies available for meclofenamic acid and Myocardial Infarction

ArticleYear
Moderate stress by cardiac pacing may induce both short term and long term cardioprotection.
    Cardiovascular research, 1993, Volume: 27, Issue:4

    Topics: Animals; Blood Pressure; Cardiac Pacing, Artificial; Electrocardiography; Heart; Male; Meclofenamic

1993
Cyclooxygenase products are not involved in the protection against myocardial infarction afforded by preconditioning in rabbit. Cyclooxygenase pathway's involvement in preconditioning.
    The American journal of cardiovascular pathology, 1992, Volume: 4, Issue:2

    Topics: Analysis of Variance; Animals; Aspirin; Coronary Circulation; Disease Susceptibility; Female; Heart

1992